Investing in hedge funds long/short equity hedge funds are

US $117.00
List price US $646.000 (69% off)
777 sold
This one's trending. 69117 have already sold.
Breathe easy. Returns accepted.

Long/short equity hedge funds are shifting focus toward undervalued dividend-paying stocks, offering income plus upside potential. This year’s yield-focused plays have attracted more conservative investors into hedge fund structures. We can report that insiders do own shares in Molecular Partners AG. As individuals, the insiders collectively own CHF4.7m worth of the CHF108m company. It is good to see some investment by insiders, but we usually like to see higher insider holdings. It might be worth checking if those insiders have been buying. Sign up for free newsletters and get more CNBC delivered to your inbox Hedge fund managers tracking banking sector equities have leveraged capital into distressed assets, anticipating a rebound from recent regulatory clarity. This approach has attracted new inflows, with $1.5B entering financial-focused strategies. Investing in hedge funds here could serve as a contrarian play for 2024 growth.